Wordt geladen...
A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantation
Hepatitis B virus (HBV) reactivation reportedly occurs frequently after hematopoietic stem cell transplantation (HSCT) in resolved HBV-infected patients. Here, 50 patients with resolved HBV infections and scheduled to undergo HSCT were enrolled; all subjects were vaccinated with three doses of hepat...
Bewaard in:
| Gepubliceerd in: | Bone Marrow Transplant |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Nature Publishing Group UK
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7329632/ https://ncbi.nlm.nih.gov/pubmed/32071416 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-020-0833-5 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|